A detailed history of Bar Harbor Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Bar Harbor Wealth Management holds 79,514 shares of ABBV stock, worth $14 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
79,514
Previous 79,860 0.43%
Holding current value
$14 Million
Previous $13.7 Million 14.64%
% of portfolio
1.01%
Previous 0.93%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$163.84 - $199.33 $56,688 - $68,968
-346 Reduced 0.43%
79,514 $15.7 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $16,872 - $19,702
-109 Reduced 0.14%
79,860 $13.7 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $158,381 - $180,461
991 Added 1.25%
79,969 $14.6 Million
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $51,462 - $57,958
-374 Reduced 0.47%
78,978 $12.2 Million
Q3 2023

Nov 28, 2023

SELL
$133.59 - $154.65 $146,013 - $169,032
-1,093 Reduced 1.36%
79,352 $11.8 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $80,831 - $100,589
-610 Reduced 0.75%
80,445 $10.8 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $178,304 - $205,343
-1,233 Reduced 1.5%
81,055 $12.9 Million
Q4 2022

Jun 09, 2023

BUY
$138.31 - $165.87 $170,536 - $204,517
1,233 Added 1.52%
82,288 $13.3 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $227,243 - $272,524
-1,643 Reduced 1.96%
82,288 $13.3 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $52,207 - $59,878
-389 Reduced 0.46%
83,931 $11.3 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $216,613 - $275,387
1,574 Added 1.9%
84,320 $12.9 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $149,269 - $185,201
-1,131 Reduced 1.35%
82,746 $13.4 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $278,136 - $351,922
-2,589 Reduced 2.99%
83,877 $11.4 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $80,970 - $91,913
-761 Reduced 0.87%
86,466 $9.33 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $45,871 - $51,103
-436 Reduced 0.5%
87,227 $9.83 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $390,172 - $429,532
-3,814 Reduced 4.17%
87,663 $9.49 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $37,347 - $50,422
-464 Reduced 0.5%
91,477 $9.8 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $55,326 - $64,934
-644 Reduced 0.7%
91,941 $8.05 Million
Q2 2020

Aug 04, 2020

SELL
$73.37 - $98.18 $645,949 - $864,376
-8,804 Reduced 8.68%
92,585 $9.09 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $255,420 - $387,248
-3,960 Reduced 3.76%
101,389 $7.73 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $212,350 - $265,696
-2,944 Reduced 2.72%
105,349 $9.33 Million
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $552,019 - $663,685
-8,765 Reduced 7.49%
108,293 $8.2 Million
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $358,196 - $457,858
-5,452 Reduced 4.45%
117,058 $8.51 Million
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $1.58 Million - $1.86 Million
-20,493 Reduced 14.33%
122,510 $9.87 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $286,565 - $353,412
-3,681 Reduced 2.51%
143,003 $13.2 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $302,827 - $336,649
-3,406 Reduced 2.27%
146,684 $13.9 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $62,397 - $73,829
-695 Reduced 0.46%
150,090 $13.9 Million
Q1 2018

Apr 06, 2018

SELL
$92.01 - $123.21 $8,372 - $11,212
-91 Reduced 0.06%
150,785 $14.3 Million
Q4 2017

Jan 17, 2018

BUY
$89.56 - $98.21 $237,154 - $260,060
2,648 Added 1.79%
150,876 $14.6 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $10.4 Million - $13.2 Million
148,228
148,228 $13.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.